Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Dopamine transporter binding in rat striatum: a comparison of [O-methyl-11C]beta-CFT and [N-methyl-11C]beta-CFT.

Yoder KK, Hutchins GD, Mock BH, Fei X, Winkle WL, Gitter BD, Territo PR, Zheng QH.

Nucl Med Biol. 2009 Jan;36(1):11-6. doi: 10.1016/j.nucmedbio.2008.10.007.

PMID:
19181264
2.

Effects of hypoxic-ischemic brain injury on striatal dopamine transporter in newborn piglets: evaluation of 11C-CFT PET/CT for DAT quantification.

Zhang YF, Wang XY, Cao L, Guo QY, Wang XM.

Nucl Med Biol. 2011 Nov;38(8):1205-12. doi: 10.1016/j.nucmedbio.2011.05.001. Epub 2011 Jul 7.

PMID:
21741256
3.

[18F]CFT ([18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: biodistribution in rats.

Haaparanta M, Bergman J, Laakso A, Hietala J, Solin O.

Synapse. 1996 Aug;23(4):321-7.

PMID:
8855517
4.

Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.

Morris ED, Babich JW, Alpert NM, Bonab AA, Livni E, Weise S, Hsu H, Christian BT, Madras BK, Fischman AJ.

Synapse. 1996 Nov;24(3):262-72.

PMID:
8923667
5.

Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.

Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N.

Synapse. 2001 Dec 15;42(4):273-80.

PMID:
11746726
6.

Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.

Pellegrino D, Cicchetti F, Wang X, Zhu A, Yu M, Saint-Pierre M, Brownell AL.

J Nucl Med. 2007 Jul;48(7):1147-53. Epub 2007 Jun 15.

7.

The influence of residual nor-β-CFT in 11C CFT injection on the Parkinson disease diagnosis: a 11C CFT PET study.

Huang T, Wang H, Tang G, Liang X, Shi X, Zhang X.

Clin Nucl Med. 2012 Aug;37(8):743-7. doi: 10.1097/RLU.0b013e31824c5fae.

PMID:
22785500
8.

Acute manganese administration alters dopamine transporter levels in the non-human primate striatum.

Chen MK, Lee JS, McGlothan JL, Furukawa E, Adams RJ, Alexander M, Wong DF, Guilarte TR.

Neurotoxicology. 2006 Mar;27(2):229-36. Epub 2005 Dec 2.

PMID:
16325911
9.

Comparison of 2beta-carbomethoxy-3beta-(4-[18F]fluorophenyl)tropane and N-(3-[18F]fluoropropyl)-2beta-carbomethoxy-3beta-(4-fluorophenyl)nortropane, tracers for imaging dopamine transporter in rat.

Marjamäki P, Haaparanta M, Forsback S, Fagerholm V, Eskola O, Grönroos T, Koivula T, Solin O.

Mol Imaging Biol. 2010 Jun;12(3):269-77. doi: 10.1007/s11307-009-0278-0. Epub 2009 Dec 1.

PMID:
19949983
10.

The DAT ligand [(18)F]PR17.MZ mirrors the in vivo pharmacokinetic profile of [(11)C]cocaine with significantly improved monoamine transporter selectivity.

Riss PJ, Piel M, Bockhart V, Bausbacher N, Buchholz HG, Lueddens H, Roesch F.

ChemMedChem. 2010 Oct 4;5(10):1686-8. doi: 10.1002/cmdc.201000237. No abstract available.

PMID:
20830722
11.

[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations.

Lundkvist C, Halldin C, Swahn CG, Hall H, Karlsson P, Nakashima Y, Wang S, Milius RA, Neumeyer JL, Farde L.

Nucl Med Biol. 1995 Oct;22(7):905-13.

PMID:
8547888
12.

In vivo dopamine transporter imaging in a unilateral 6-hydroxydopamine rat model of Parkinson disease using 11C-methylphenidate PET.

Sossi V, Dinelle K, Jivan S, Fischer K, Holden JE, Doudet D.

J Nucl Med. 2012 May;53(5):813-22. doi: 10.2967/jnumed.111.101436. Epub 2012 Apr 9.

13.

SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.

Fischman AJ, Babich JW, Elmaleh DR, Barrow SA, Meltzer P, Hanson RN, Madras BK.

J Nucl Med. 1997 Jan;38(1):144-50.

14.

Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.

Moritz AE, Foster JD, Gorentla BK, Mazei-Robison MS, Yang JW, Sitte HH, Blakely RD, Vaughan RA.

J Biol Chem. 2013 Jan 4;288(1):20-32. doi: 10.1074/jbc.M112.407874. Epub 2012 Nov 16.

15.

Correlative single photon emission computed tomography imaging of [123I]altropane binding in the rat model of Parkinson's.

Gleave JA, Farncombe TH, Saab C, Doering LC.

Nucl Med Biol. 2011 Jul;38(5):741-9. doi: 10.1016/j.nucmedbio.2010.12.006. Epub 2011 Mar 30.

PMID:
21718949
16.

[18F]CFT [(18F)WIN 35,428], a radioligand to study the dopamine transporter with PET: characterization in human subjects.

Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O, Hietala J.

Synapse. 1998 Mar;28(3):244-50.

PMID:
9488509
17.

[(11)C, (127)I] Altropane: a highly selective ligand for PET imaging of dopamine transporter sites.

Fischman AJ, Bonab AA, Babich JW, Livni E, Alpert NM, Meltzer PC, Madras BK.

Synapse. 2001 Mar 15;39(4):332-42.

PMID:
11169784
19.

Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain.

Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N, Nakanishi S.

Brain Res. 1999 Dec 4;849(1-2):85-96.

PMID:
10592290
20.

Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.

Andringa G, Drukarch B, Bol JG, de Bruin K, Sorman K, Habraken JB, Booij J.

Neuroimage. 2005 Jul 15;26(4):1150-8.

PMID:
15908232

Supplemental Content

Support Center